Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
评价阿立哌唑长效肌内注射剂相对于阿立哌唑片剂治疗成人急性期精神分裂症受试者的非劣效性
CTR20170309Phase 3Active
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in schizophrenia, sponsored by Otsuka Pharmaceutical Co., Ltd.. Started May 2017; status: active.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on CTR20170309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170309.